These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 27574930)
1. Delayed Presentation of Hepatocellular Liver Injury After Nintedanib Administration. Olin JL; Woods JA; Garner SJ Am J Ther; 2017; 24(1):e107-e108. PubMed ID: 27574930 [No Abstract] [Full Text] [Related]
2. Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis. Ikeda S; Sekine A; Baba T; Yamanaka Y; Sadoyama S; Yamakawa H; Oda T; Okuda R; Kitamura H; Okudela K; Iwasawa T; Ohashi K; Takemura T; Ogura T Sci Rep; 2017 Sep; 7(1):10811. PubMed ID: 28883482 [TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience. Ikeda S; Sekine A; Baba T; Yamakawa H; Morita M; Kitamura H; Ogura T Respir Investig; 2017 Jan; 55(1):51-54. PubMed ID: 28012494 [No Abstract] [Full Text] [Related]
4. [Liver toxicity of laxatives. Results of exposure to phenolisatines]. Henning H; von Braun HH; Look D; Lüders CJ; Vogel HM Z Gastroenterol; 1973 Mar; 11(2):75-84. PubMed ID: 4803412 [No Abstract] [Full Text] [Related]
5. Safety management of treatment with nintedanib in clinical practice of IPF. Azuma A Respir Investig; 2017 Jan; 55(1):1. PubMed ID: 28012486 [No Abstract] [Full Text] [Related]
6. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. Richeldi L; Costabel U; Selman M; Kim DS; Hansell DM; Nicholson AG; Brown KK; Flaherty KR; Noble PW; Raghu G; Brun M; Gupta A; Juhel N; Klüglich M; du Bois RM N Engl J Med; 2011 Sep; 365(12):1079-87. PubMed ID: 21992121 [TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil. Pereira CAC; Baddini-Martinez JA; Baldi BG; Jezler SFO; Rubin AS; Alves RLR; Zonzin GA; Quaresma M; Trampisch M; Rabahi MF J Bras Pneumol; 2019 Sep; 45(5):e20180414. PubMed ID: 31531619 [TBL] [Abstract][Full Text] [Related]
8. [Liver damage caused by laxatives]. Wildhirt E Dtsch Med Wochenschr; 1972 Aug; 97(32):1181-2. PubMed ID: 5044649 [No Abstract] [Full Text] [Related]
9. Pneumatosis Intestinalis Associated with the Tyrosine Kinase Inhibitor Nintedanib. Poor A; Braman SS Lung; 2018 Jun; 196(3):373-375. PubMed ID: 29721603 [No Abstract] [Full Text] [Related]
10. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. Reynolds TB; Peters RL; Yamada S N Engl J Med; 1971 Oct; 285(15):813-20. PubMed ID: 4108110 [No Abstract] [Full Text] [Related]
11. Acute drug induced hepatitis due to erlotinib. Ramanarayanan J; Scarpace SL JOP; 2007 Jan; 8(1):39-43. PubMed ID: 17228132 [TBL] [Abstract][Full Text] [Related]
12. Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis. Keating GM Drugs; 2015 Jul; 75(10):1131-40. PubMed ID: 26063212 [TBL] [Abstract][Full Text] [Related]
13. Nintedanib: a novel therapeutic approach for idiopathic pulmonary fibrosis. Dimitroulis IA Respir Care; 2014 Sep; 59(9):1450-5. PubMed ID: 24782550 [TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis. Corte T; Bonella F; Crestani B; Demedts MG; Richeldi L; Coeck C; Pelling K; Quaresma M; Lasky JA Respir Res; 2015 Sep; 16():116. PubMed ID: 26400368 [TBL] [Abstract][Full Text] [Related]
15. The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis. Cottin V Expert Opin Drug Saf; 2017 Jul; 16(7):857-865. PubMed ID: 28571476 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of severity of toxic hepatitis in acute poisoning with chlorinated hydrocarbons after changes of the activity of aminotransferases and sorbitol dehydrogenase]. Natsiuk MV; Lipkan GN; Chernukha FS Gig Tr Prof Zabol; 1974 Jun; 18(6):53. PubMed ID: 4845523 [No Abstract] [Full Text] [Related]
17. Is nintedanib effective for idiopathic pulmonary fibrosis? Jeldres A; Labarca G Medwave; 2017 Apr; 17(Suppl2):e6918. PubMed ID: 28430774 [TBL] [Abstract][Full Text] [Related]